ZQX-12341-83358
4 vaccinations
4 coded responses
32 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 930 / CA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
-
2021-02-01
Survey response — day 21, dose 2MedDRA: Unevaluable event — Feeling: FairFree text: Digestion issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-04-12
- 2021-07-12
-
2021-08-26
Dose 3 — Pfizer-BioNTech
-
2021-09-24
Survey response — day 28, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: Pregnant as of 9/3/21MedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
- 2021-10-07
- 2021-11-25
- 2022-02-24
- 2022-08-28
-
2022-09-13
Dose 4 — ModernaCo-administered: Flu
- 2022-09-23
-
2022-09-27
Survey response — day 14, dose 4MedDRA: Nasopharyngitis — Feeling: FairFree text: Common coldMedDRA releases: 2024-11 · check-in free text available
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-12-13
-
2023-03-14
Survey response — 6 months, dose 4MedDRA: Silent thyroiditis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-14
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-08-26 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-12 | priority 2/3 | |
| 2023-03-14 | Successful 2023-03-15 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 3 — day 21, dose 2
Symptoms: Digestion issues
Release 9 — day 28, dose 3
Symptoms: Pregnant as of 9/3/21
Release 12 — day 14, dose 4
Symptoms: Common cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Silent thyroiditis | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release